mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
0.023 |
0.7 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.7 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |